I-MAB (IMAB)
1.76
-0.01
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
I-MAB Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2020 | 374.88M |
September 30, 2019 | 5.617M |
Date | Value |
---|---|
September 30, 2018 | 217.42M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
5.617M
Minimum
Sep 2019
374.88M
Maximum
Sep 2020
190.25M
Average
190.25M
Median
Cash from Financing (Quarterly) Benchmarks
Summit Therapeutics Inc | 0.485M |
Verastem Inc | 0.846M |
CEL-SCI Corp | 6.596M |
AIM ImmunoTech Inc | 0.147M |
IGC Pharma Inc | -0.001M |
Cash from Financing (Quarterly) Related Metrics
Free Cash Flow Yield | -115.2% |